These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12612467)

  • 1. Cardiac innervation and clinical correlates in idiopathic Parkinson's disease.
    Akincioglu C; Unlu M; Tunc T
    Nucl Med Commun; 2003 Mar; 24(3):267-71. PubMed ID: 12612467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
    Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease.
    Kashihara K; Imamura T; Shinya T
    Parkinsonism Relat Disord; 2010 May; 16(4):252-5. PubMed ID: 20097595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
    Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
    J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
    Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
    Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
    Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
    J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
    Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
    Parkinsonism Relat Disord; 2006 Jun; 12(5):284-8. PubMed ID: 16549383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
    Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M
    J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac ¹²³I-MIBG scintigraphy as an outcome-predicting tool for subthalamic nucleus stimulation in Parkinson's disease.
    Yamada K; Shiraishi SY; Hamasaki T; Kuratsu J
    Acta Neurochir (Wien); 2010 Dec; 152(12):2063-8. PubMed ID: 20927559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
    Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
    Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
    J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.
    Kitayama M; Wada-Isoe K; Irizawa Y; Nakashima K
    J Neurol Sci; 2008 Jan; 264(1-2):22-6. PubMed ID: 17706675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic blood pressure profile correlates with cardiac 123I-MIBG uptake in patients with Parkinson's disease.
    Manabe Y; Fujii D; Kono S; Sakai Y; Tanaka T; Narai H; Omori N; Imai Y; Abe K
    J Neurol Sci; 2011 Aug; 307(1-2):153-6. PubMed ID: 21640359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early alterations of adrenergic cardiac function in Parkinson's disease].
    Campos V; Rebollo AC; Jiménez-Hoyuela JM; Gómez-Doblas JJ; Medialdea P; Vila E; Gutiérrez-Hurtado A
    Neurologia; 2004 Mar; 19(2):53-8. PubMed ID: 14986180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the relationship between muscle sympathetic nerve activity and cardiac 123I-metaiodobenzylguanidine uptake in patients with Parkinson's disease.
    Shindo K; Kaneko E; Watanabe H; Sugimoto T; Ohta E; Ohashi K; Nagasaka T; Shiozawa Z
    Mov Disord; 2005 Nov; 20(11):1419-24. PubMed ID: 16007621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
    Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
    Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PR Prolongation and Cardiac 123I-MIBG Uptake Reduction in Parkinson's Disease.
    Mochizuki H; Ebihara Y; Ugawa Y; Ishii N; Taniguchi A; Nagamachi S; Shiomi K; Nakazato M
    Eur Neurol; 2015; 74(1-2):107-11. PubMed ID: 26303385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson's disease.
    Yoshita M; Hayashi M; Hirai S
    Nucl Med Commun; 1998 Feb; 19(2):137-42. PubMed ID: 9548197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.